Previously, we successfully induced CR in a patient with relapsed ETP‐ALL using a regimen consisting of VEN, HHT, cytarabine, and granulocyte colony‐stimulating factor (G‐CSF) (referred to as the V‐HAG regimen), followed by bridging to allo‐HSCT [12]. The gene discussed is CSF3; the disease is acute lymphoblastic leukemia.